Request for Covid-19 Impact Assessment of this Report
Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Antipsychotic Drugs Market. Due to greater awareness for mental health issues and disorders as well as higher per capita income, North America has emerged as the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 increasing cases of bipolar and schizophrenic disorders and thus increased demand for antipsychotic drugs. Rising disposable income and growing awareness for mental health issues treatment will also boost growth in this region.
Major market player included in this report are:
Johnson & Johnson
Pfizer, Inc.
Eli Lilly & Co.
Bristol-Myers Squibb Company
AstraZeneca
Glaxo SmithKline, Plc
Allergan
Otsuka Pharmaceutical Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Vanda Pharmaceuticals Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
First Generation/Standard/Typical Antipsychotics Drug
Second Generation/Atypical Antipsychotics Drug
Third generation Antipsychotics Drug
Other market
By Application:
Schizophrenia
Bipolar Disorder
Depression
Dementia
Other psychotic disorders
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Antipsychotic Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Antipsychotic Drugs Market, by Drug Class, 2019-2027 (USD Billion)
1.2.2. Antipsychotic Drugs Market, by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antipsychotic Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antipsychotic Drugs Market Dynamics
3.1. Antipsychotic Drugs Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increased cases of psychotic disorders
3.1.1.2. Increased awareness for mental health and well-being
3.1.2. Market Challenges
3.1.2.1. Stigma attached to mental health disorders
3.1.3. Market Opportunities
3.1.3.1. Governmental support to raise awareness for treatment
Chapter 4. Global Antipsychotic Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antipsychotic Drugs Market, by Drug Class
5.1. Market Snapshot
5.2. Global Antipsychotic Drugs Market by Drug Class, Performance - Potential Analysis
5.3. Global Antipsychotic Drugs Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
5.4. Antipsychotic Drugs Market, Sub Segment Analysis
5.4.1. First Generation/Standard/Typical Antipsychotics Drug
5.4.2. Second Generation/Atypical Antipsychotics Drug
5.4.3. Third generation Antipsychotics Drug
5.4.4. Other market
Chapter 6. Global Antipsychotic Drugs Market, by Application
6.1. Market Snapshot
6.2. Global Antipsychotic Drugs Market by Application, Performance - Potential Analysis
6.3. Global Antipsychotic Drugs Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4. Antipsychotic Drugs Market, Sub Segment Analysis
6.4.1. Schizophrenia
6.4.2. Bipolar Disorder
6.4.3. Depression
6.4.4. Dementia
6.4.5. Other psychotic disorders
Chapter 7. Global Antipsychotic Drugs Market, Regional Analysis
7.1. Antipsychotic Drugs Market, Regional Market Snapshot
7.2. North America Antipsychotic Drugs Market
7.2.1. U.S. Antipsychotic Drugs Market
7.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Antipsychotic Drugs Market
7.3. Europe Antipsychotic Drugs Market Snapshot
7.3.1. U.K. Antipsychotic Drugs Market
7.3.2. Germany Antipsychotic Drugs Market
7.3.3. France Antipsychotic Drugs Market
7.3.4. Spain Antipsychotic Drugs Market
7.3.5. Italy Antipsychotic Drugs Market
7.3.6. Rest of Europe Antipsychotic Drugs Market
7.4. Asia-Pacific Antipsychotic Drugs Market Snapshot
7.4.1. China Antipsychotic Drugs Market
7.4.2. India Antipsychotic Drugs Market
7.4.3. Japan Antipsychotic Drugs Market
7.4.4. Australia Antipsychotic Drugs Market
7.4.5. South Korea Antipsychotic Drugs Market
7.4.6. Rest of Asia Pacific Antipsychotic Drugs Market
7.5. Latin America Antipsychotic Drugs Market Snapshot
7.5.1. Brazil Antipsychotic Drugs Market
7.5.2. Mexico Antipsychotic Drugs Market
7.6. Rest of The World Antipsychotic Drugs Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Johnson & Johnson
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Pfizer, Inc.
8.2.3. Eli Lilly & Co.
8.2.4. Bristol-Myers Squibb Company
8.2.5. AstraZeneca
8.2.6. Glaxo SmithKline, Plc
8.2.7. Allergan
8.2.8. Otsuka Pharmaceutical Co., Ltd.
8.2.9. Sumitomo Dainippon Pharma Co., Ltd.
8.2.10. Vanda Pharmaceuticals Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
TABLE 1. Global Antipsychotic Drugs Market, report scope
TABLE 2. Global Antipsychotic Drugs Market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Antipsychotic Drugs Market estimates & forecasts by Drug Class 2018-2027 (USD Billion)
TABLE 4. Global Antipsychotic Drugs Market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 5. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. U.S. Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 17. U.S. Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. Canada Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Canada Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 20. Canada Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. UK Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. UK Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. UK Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Germany Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Germany Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Germany Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. RoE Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. RoE Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. RoE Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. China Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. China Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. China Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. India Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. India Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. India Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Japan Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Japan Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Japan Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. RoAPAC Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. RoAPAC Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. RoAPAC Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. Brazil Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. Brazil Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. Brazil Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Mexico Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. Mexico Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. Mexico Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. RoLA Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. RoLA Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. RoLA Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Row Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Row Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Row Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Antipsychotic Drugs Market
TABLE 55. List of primary sources, used in the study of global Antipsychotic Drugs Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...